• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
DeviceiStent inject Trabecular Micro-Bypass System (Model G2-M-IS)
Generic Nameintraocular pressure lowering implant
Glaukos Corporation
229 avenida fabricante
san clemente, CA 92672
PMA NumberP170043
Supplement NumberS004
Date Received05/02/2019
Decision Date05/30/2019
Product Code OGO 
Advisory Committee Ophthalmic
Supplement Type30-day notice
Supplement Reason process change - manufacturer/sterilizer/packager/supplier
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Modification to the endotoxin specification for the injector handpiece for the Glaukos® iStent inject® Trabecular Micro-Bypass System (Model G2-M-IS).